Doppelt hält nicht besser: Antithrombotika nach Schlaganfall und Vorhofflimmern (ATIS-NVAF)

from Intensive Care Breakdown · host Dr. Sebastian Groß

Die ATIS-NVAF-Studie liefert erstmals randomisierte Daten zur Frage, ob Patient:innen mit Schlaganfall, Vorhofflimmern und Atherosklerose von einer Kombination aus Antikoagulanz und Thrombozytenhemmer profitieren. Das Ergebnis: kein klinischer Vorteil – aber deutlich mehr Blutungen. Wir besprechen Design, Ergebnisse und die Konsequenzen für die Praxis.https://pubmed.ncbi.nlm.nih.gov/41051787/

Episode metadata supplied by the publisher feed · Published Oct 19, 2025

Embed this episode

Attribution link and audio player

Ready to play

Doppelt hält nicht besser: Antithrombotika nach Schlaganfall und Vorhofflimmern (ATIS-NVAF)

0:00 8:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Intensive Care Breakdown?

This episode is 8 minutes long.

When was this Intensive Care Breakdown episode published?

This episode was published on October 19, 2025.

Can I download this Intensive Care Breakdown episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!